Status and phase
Conditions
Treatments
About
An open label, ascending dose study for adult subjects with T-cell Large Granular Lymphocytic Leukemia (T-LGLL)
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Is at least 18 years of age.
Has body mass index (BMI) ≤35 kg/m2.
Has a documented diagnosis of T LGLL.
Has any 1 or more of the following at Screening:
Has adequate hepatic and renal function at Screening, as indicated by:
Agrees to adhere to the current Centers for Disease Control advice regarding minimizing exposure to severe acute respiratory syndrome coronavirus 2 (SARS CoV 2) from the first Screening Visit until the End of Study (EOS)/Early Termination Visit (ETV).
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
30 participants in 5 patient groups
Loading...
Central trial contact
Michael McClain
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal